Red X iconGreen tick iconYellow tick icon

Paul Chin

Senior Lecturer

MB ChB PhD

Email paul.chin@otago.ac.nz

Paul Chin is a clinical pharmacologist, employed as a Senior Lecturer at the University of Otago, Christchurch and Senior Medical Officer at Te Whatu Ora Health New Zealand – Waitaha Canterbury.

Research interests include therapeutic drug monitoring (including anticoagulants and antimicrobials), quality use of medicines, electronic prescribing, and clinical decision support.

Publications

Morahan, M.-C., Yorkston, D., Knight, J., Borrie, T., Hastie, B., & Chin, P. (2023). The Covid-19 pandemic perspective from a New Zealand medicines information service. Pharmacy Education, 23(6), (pp. 176-177). doi: 10.46542/pe.2023.236.158191

Pairman, L., Chin, P., McNeill, R., & Doogue, M. (2023). The effect of compulsory indications in electronic hospital prescriptions on prescriber behaviour. Proceedings of the Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists (ASCEPT) Annual Scientific Meeting: Transformational Pharmacology & Toxicology. 435. Retrieved from https://www.asceptasm.com

Barclay, M. L., Keating, P. E., Hock, B. D., Chin, P. K. L., & O'Donnell, J. L. (2023). Infliximab or adalimumab antidrug-antibody complex size has more clinical value than concentration. Proceedings of the Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists (ASCEPT) Annual Scientific Meeting: Transformational Pharmacology & Toxicology. 235. Retrieved from https://www.asceptasm.com

Barclay, M. L., Keating, P. E., Hock, B. D., Smith, S. M., Chin, P. K. L., & O'Donnell, J. L. (2023). Four-year review of New Zealand laboratory infliximab and adalimumab concentration results indicating high potential for improved dosing. Proceedings of the Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists (ASCEPT) Annual Scientific Meeting: Transformational Pharmacology & Toxicology. P513. Retrieved from https://www.asceptasm.com

Zhang, M., Moore, G., Chin, P. K. L., & Doogue, M. (2023). An efficient HILIC-MS/MS method for monitoring metformin in human plasma. Proceedings of the Australasian Society of Clinical & Experimental Pharmacologists & Toxicologists (ASCEPT) Annual Scientific Meeting: Transformational Pharmacology & Toxicology. P510. Retrieved from https://www.asceptasm.com

Back to top